Accessibility Menu
0913693 B.c. logo

0913693 B.c.

(OTC) REPCF

Current Price$0.00
Market Cap$7.00K
Since IPO (2010)-100%
5 Year-100%
1 Year-95%
1 Month+0%

0913693 B.c. Financials at a Glance

Market Cap

$7.00K

Revenue (TTM)

CA$442.11K

Net Income (TTM)

CA$7.77M

EPS (TTM)

-$0.08

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-145.26 (Low)

Price

$0.00

Volume

39,772

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 4, 2025

REPCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 0913693 B.c.

Industry

Life Sciences Tools and Services

CEO

Andrew Schutte

Headquarters

Vancouver, BC V6C 3P1, CA

REPCF Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-1%

Net Income Margin

-28%

Return on Equity

0%

Return on Capital

23%

Return on Assets

-34%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.00K

Shares Outstanding

70.00M

Volume

39.77K

Avg. Volume

1.41K

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

CA$237.84K

EBITDA

CA$237.84K

Operating Cash Flow

-CA$296.08K

Capital Expenditure

CA$4.12

Free Cash Flow

-CA$296.08K

Cash & ST Invst.

CA$5.52K

Total Debt

CA$1.02M

0913693 B.c. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$88.66K

+44.3%

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.00K

N/A

Market Cap/Employee

$7.00K

N/A

Employees

1

N/A

Net Income

-CA$47.58K

+99.4%

EBITDA

CA$78.39K

+154.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$815.10

-92.2%

Total Debt

CA$1.07M

+24.2%

Accounts Receivable

CA$38.08K

+774.5%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$1.07M

+34.0%

Return on Assets

-33.81%

N/A

Return on Invested Capital

23.46%

N/A

Free Cash Flow

-CA$34.35K

+77.3%

Operating Cash Flow

-CA$34.35K

+77.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RGBPRegen BioPharma, Inc.
$0.00+100.00%
HAVLFHAVN Life Sciences Inc.
$0.00+0.00%
SIGYSigyn Therapeutics, Inc.
$0.04-10.26%
AXIMAXIM Biotechnologies, Inc.
$0.00-20.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$185.00-0.04%
NOKNokia
$13.49-0.02%
AALAmerican Airlines Group
$15.99+0.04%
PFEPfizer
$25.21-0.03%

Questions About REPCF

What is the current price of 0913693 B.c.?

0913693 B.c. is trading at $0.00 per share.

What is the 52-week range for 0913693 B.c.?

Over the past 52 weeks, 0913693 B.c. has traded between $0.00 and $0.00.

How much debt does 0913693 B.c. have?

As of the most recent reporting period, 0913693 B.c. reported total debt of CA$761.60K.

How much cash does 0913693 B.c. have on hand?

0913693 B.c. reported CA$582.57 in cash and cash equivalents in its most recent financial results.

What is 0913693 B.c.’s dividend yield?

0913693 B.c. does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.